0
0
Loading version...
🔄 Update App
🔍 Check for Updates
Test Notification
🔔 Enable Notifications
📰 Fetch NHK News
🚀 Fetch TechCrunch News
🧪 Experiment
📰 Article Management
📚 Reading List
🎤 Speaking List
📊 Statistics
💻 Software Statistics
Push Admin
Edit Reading
Back to List
Basic Information
Title
Please enter a title.
URL
Please enter a valid URL.
Date
カテゴリID
画像ファイル名
統計情報
単語数:
120語
読了回数:
0回
作成日:
2022/10/13 20:33
更新日:
2025/12/09 12:46
本文
本文
US drug maker Pfizer has asked Japan's health ministry to approve the use of its updated coronavirus vaccine for children aged five to 11. The firm says the vaccine is effective against the prevailing Omicron BA.5 subvariant. Pfizer said it filed the request on Thursday. The so-called bivalent vaccine targets the BA.4 and BA.5 subvariants, as well as earlier strains. Messenger RNA-based vaccines enable the human body to create spike proteins and build up an immune response. The vaccine for the BA.5 subvariant is currently available for those aged 12 or older in Japan. On Wednesday, the US Centers for Disease Control and Prevention approved the use of the firm's updated coronavirus booster shots for children as young as five.
本文を入力してください。
メモ
メモ・感想
キャンセル
更新
Debug Info:
Saved State:
-
Redirected Flag:
-
Current URL:
-
Refresh
Close
Debug
Send Report
Send Report
Draw Arrow
Clear
Message:
Cancel
Send
